AKCOME vs Luxor Solar - solar panel manufacturer comparison

AKCOME is a Chinese manufacturer founded in 2006 and listed on the Shenzhen Stock Exchange, with production facilities primarily in Jiangsu Province. The company has attained Bloomberg Tier 1 bankability status and has built a substantial HJT cell and module manufacturing base, with publicly announced capacity expansion targets reaching several gigawatts. A note of caution applies, however: a subsidiary, Zhejiang Akcome Photoelectricity Technology, filed for bankruptcy in 2024 citing debt obligations, which introduces financial uncertainty at the group level. Luxor Solar GmbH, by contrast, was founded in Stuttgart in 2007 and remains an owner-managed company headquartered in Germany, active in over 85 countries and reporting a production capacity of around 6.8 GW. Luxor holds the EuPD Research "Top Brand PV" seal for Germany and several European markets and has been recognized for strong creditworthiness - giving it a firmer standing in European project-finance circles.

On the product side, AKCOME has focused its R&D effort heavily on heterojunction (HJT) technology, positioning itself as a specialist in that cell architecture and reportedly achieving competitive cell efficiencies at mass-production scale. The company has also established a perovskite pilot line, signaling ambitions in next-generation cell research. Its modules target both residential and commercial-scale applications. Luxor Solar offers a broader technology mix under its Eco Line brand, combining HJT and TOPCon cell types across a portfolio that skews toward bifacial glass-glass modules backed by 30-year product and performance warranties. That diversity makes Luxor a more flexible supplier for installers working across rooftop and ground-mount segments simultaneously.

For a European buyer in 2025, Luxor Solar is generally the more straightforward default - its German headquarters, multilingual support network, and strong warranty terms align well with the expectations of local financiers and EPCs. AKCOME can be a compelling alternative where HJT-specific performance is a priority and pricing is a constraint, but prospective buyers should closely monitor the group's ongoing financial restructuring before entering a long-term supply agreement.

Generated by Claude Sonnet · 2026-05-19